A. Zh. Suigenbayev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
A. Zh. Suigenbayev has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- A. B. Mergalimova
Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan
1 shared publication - Elmira Yelshibayeva
RSE “Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan”, Astana 010000, Kazakhstan
1 shared publication - Zh. B. Ospanova
Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan
1 shared publication
Latest Publications
- Open Access
- 25 July 2025
- Published by Luchevaya Diagnostika in Journal of radiology and nuclear medicine
- Vol. 105 (6) , 314-324
Levamisole-induced leukoencephalopathy: a rare drug side effect
Levamisole is an antihelminthic drug that is widely used in clinical practice. One of its rare side effects is the development of levamisole-associated multifocal inflammatory leukoencephalopathy, which progresses 2–8 weeks after treatment and is characterized by brain demyelination and white matter damage. The article describes a case of levamisole-induced leukoencephalopathy, which should be differentiated from multiple sclerosis, acute disseminated encephalomyelitis, and neuromyelitis optica.
- 25 July 2025
- Published by Luchevaya Diagnostika in Journal of radiology and nuclear medicine
- Vol. 105 (6) , 314-324
Open AccessLevamisole-induced leukoencephalopathy: a rare drug side effect
Levamisole is an antihelminthic drug that is widely used in clinical practice. One of its rare side effects is the development of levamisole-associated multifocal inflammatory leukoencephalopathy, which progresses 2–8 weeks after treatment and is characterized by brain demyelination and white matter damage. The article describes a case of levamisole-induced leukoencephalopathy, which should be differentiated from multiple sclerosis, acute disseminated encephalomyelitis, and neuromyelitis optica.